The 10 references in paper R. Kozlov S., O. Sivaya V., A. Shevelev N., Р. Козлов С., О. Сивая В., А. Шевелев Н. (2014) “Перспективы применения новых цефалоспоринов в терапии пневмококковых инфекций // Perspective of new cephalosporins for treatment of pneumococcal infections” / spz:neicon:pulmonology:y:2011:i:3:p:53-58

1
Bartlett J.С., Mundy L.M., Community-acquired pneumonia. N. Engl. J. Med. 1995; 333: 1618–1624.
(check this in PDF content)
2
Heffelfinger J.D., Dowell S.F., Jorgensen J.H. et. al. Managment of community-acquired pneumoniae in the era of pneumococcal resistance: A report from the Drug-Resistance Streptococcus Pneumoniae Therapeutic Working Group. Arch. Intern. Med. 2000; 160: 1399–1408.
(check this in PDF content)
3
Gooch III W.M., Golanty S.A.A review of treatment guidelines in an era of drug-resistant pneumococcal pathogens: a review of otitis media guidelines. Laguna Niguel, CA: The Institute of Medical Studies; 2000.
(check this in PDF content)
4
CLSI. Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. CLSI document M100-S20. Wayne, PA: Clinical and Laboratory Standаrds Institute; 2010. 88–91.
(check this in PDF content)
5
European Committee on Antimicrobial Susceptibility Testing. Breakpoints tables for interpretation of MICs and zone diameters. Version 1.3. January 5, 2011. Http://www.eucast.org/fileadmin/src/media/PDFs/ EUCAST_files/Disk_test_documents/EUCAST_break5 points_v1.3_pdf.pdf
(check this in PDF content)
6
Karlowsky J.A., Jones M.E., Draghi D.C. et al. In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren. Diagn. Microbiol. Infect. Dis. 2002; 42 (1): 59–64.
(check this in PDF content)
7
Statement 2003 CA-SFM. Zone sizes and MIC breakpoints for non-fastidious organisms. Clin. Microbiol. Infect. 2003; 2: S46–S48.
(check this in PDF content)
8
Jenkins S.G., Brown S.D., Farrell D.J.Trends in antibacterial resistance among Streaptococcus pneumoniae isolated in the USA: update from Protekt US Years 1–4. Ann. Clin. Microbiol. Antimicrob. 2008; 7 (1): 1.
(check this in PDF content)
9
Perez Trallero E., Martin Yerrero J.E., Mazon A. et al. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996–1997 to 2006–2007). Antimicrob Agents Chemother 2008; 54 (7): 2953–2959.
(check this in PDF content)
10
Inoue M., Farrell D.J., Kaneko K. et al. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1–5 (1999–2004). Microb. Drug Resist. 2008; 14 (72): 109–117. Информация об авторах
(check this in PDF content)